アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/06/12 | 1,421 | 1,422.5 | 1,410 | 1,416.5 | -2.5 | -0.2% | 4,172,200 |
2025/06/11 | 1,421 | 1,432 | 1,415.5 | 1,419 | +1.5 | +0.1% | 4,119,000 |
2025/06/10 | 1,410.5 | 1,422 | 1,402.5 | 1,417.5 | +15 | +1.1% | 4,395,900 |
2025/06/09 | 1,416 | 1,416 | 1,402.5 | 1,402.5 | +6.5 | +0.5% | 2,867,300 |
2025/06/06 | 1,400.5 | 1,404.5 | 1,394.5 | 1,396 | +0.5 | ±0% | 3,214,800 |
2025/06/05 | 1,406 | 1,409 | 1,384 | 1,395.5 | -20 | -1.4% | 4,880,800 |
2025/06/04 | 1,425 | 1,431 | 1,413.5 | 1,415.5 | -12.5 | -0.9% | 4,154,000 |
2025/06/03 | 1,420 | 1,433.5 | 1,412.5 | 1,428 | +3.5 | +0.2% | 3,938,100 |
2025/06/02 | 1,425 | 1,431.5 | 1,412 | 1,424.5 | -4.5 | -0.3% | 3,699,800 |
2025/05/30 | 1,400 | 1,431 | 1,395 | 1,429 | +15.5 | +1.1% | 8,479,800 |
2025/05/29 | 1,402 | 1,419 | 1,402 | 1,413.5 | +13 | +0.9% | 4,305,700 |
2025/05/28 | 1,411.5 | 1,414.5 | 1,400.5 | 1,400.5 | -4 | -0.3% | 4,481,200 |
2025/05/27 | 1,396.5 | 1,408.5 | 1,393 | 1,404.5 | +8 | +0.6% | 3,161,000 |
2025/05/26 | 1,385 | 1,400 | 1,382.5 | 1,396.5 | +3.5 | +0.3% | 3,092,800 |
2025/05/23 | 1,409 | 1,419.5 | 1,392.5 | 1,393 | +2.5 | +0.2% | 5,207,200 |
2025/05/22 | 1,374 | 1,396 | 1,373 | 1,390.5 | +10.5 | +0.8% | 4,625,100 |
2025/05/21 | 1,380 | 1,383.5 | 1,374 | 1,380 | +15.5 | +1.1% | 3,893,900 |
2025/05/20 | 1,388 | 1,388.5 | 1,356.5 | 1,364.5 | -10 | -0.7% | 5,338,900 |
2025/05/19 | 1,381 | 1,390 | 1,374.5 | 1,374.5 | +8.5 | +0.6% | 4,948,600 |
2025/05/16 | 1,363 | 1,368 | 1,351.5 | 1,366 | +25 | +1.9% | 4,169,400 |
2025/05/15 | 1,333 | 1,350 | 1,328.5 | 1,341 | -12.5 | -0.9% | 5,150,700 |
2025/05/14 | 1,370 | 1,380.5 | 1,353 | 1,353.5 | -18.5 | -1.3% | 5,894,500 |
2025/05/13 | 1,402 | 1,406 | 1,368 | 1,372 | +30 | +2.2% | 8,960,300 |
2025/05/12 | 1,379.5 | 1,380 | 1,330 | 1,342 | -54 | -3.9% | 14,000,200 |
2025/05/09 | 1,400 | 1,402.5 | 1,385 | 1,396 | -12 | -0.9% | 8,774,800 |
2025/05/08 | 1,431 | 1,434.5 | 1,399 | 1,408 | -23.5 | -1.6% | 5,653,800 |
2025/05/07 | 1,458.5 | 1,459.5 | 1,414 | 1,431.5 | -26.5 | -1.8% | 9,074,700 |
2025/05/02 | 1,438 | 1,464 | 1,434 | 1,458 | +19 | +1.3% | 5,931,000 |
2025/05/01 | 1,435.5 | 1,439.5 | 1,420.5 | 1,439 | +11.5 | +0.8% | 5,161,200 |
2025/04/30 | 1,433.5 | 1,446.5 | 1,419 | 1,427.5 | -7.5 | -0.5% | 9,544,200 |
2025/04/28 | 1,452 | 1,462 | 1,427.5 | 1,435 | +53.5 | +3.9% | 9,907,900 |
2025/04/25 | 1,374 | 1,388.5 | 1,366.5 | 1,381.5 | +21 | +1.5% | 5,515,400 |
2025/04/24 | 1,368 | 1,375 | 1,356 | 1,360.5 | -7.5 | -0.5% | 5,031,700 |
2025/04/23 | 1,377.5 | 1,378.5 | 1,357 | 1,368 | +18.5 | +1.4% | 4,657,900 |
2025/04/22 | 1,332.5 | 1,349.5 | 1,323.5 | 1,349.5 | +14 | +1% | 3,721,000 |
2025/04/21 | 1,348 | 1,348.5 | 1,327.5 | 1,335.5 | -17 | -1.3% | 3,499,900 |
2025/04/18 | 1,348 | 1,353 | 1,328.5 | 1,352.5 | +25.5 | +1.9% | 3,358,000 |
2025/04/17 | 1,321 | 1,328 | 1,314 | 1,327 | +4.5 | +0.3% | 3,912,800 |
2025/04/16 | 1,330 | 1,334.5 | 1,314.5 | 1,322.5 | -14.5 | -1.1% | 4,777,600 |
2025/04/15 | 1,332 | 1,350 | 1,328 | 1,337 | +24 | +1.8% | 5,711,400 |
2025/04/14 | 1,290 | 1,322.5 | 1,290 | 1,313 | +43.5 | +3.4% | 5,497,800 |
2025/04/11 | 1,253.5 | 1,276.5 | 1,251.5 | 1,269.5 | -64 | -4.8% | 10,637,500 |
2025/04/10 | 1,350 | 1,361 | 1,320.5 | 1,333.5 | +76.5 | +6.1% | 10,732,500 |
2025/04/09 | 1,328 | 1,331.5 | 1,243.5 | 1,257 | -84 | -6.3% | 13,738,400 |
2025/04/08 | 1,329.5 | 1,344 | 1,315 | 1,341 | +39.5 | +3% | 9,629,900 |
2025/04/07 | 1,300 | 1,337 | 1,274 | 1,301.5 | -88.5 | -6.4% | 11,695,000 |
2025/04/04 | 1,372 | 1,408 | 1,372 | 1,390 | +14.5 | +1.1% | 10,137,500 |
2025/04/03 | 1,375 | 1,388.5 | 1,365 | 1,375.5 | -28.5 | -2% | 11,161,900 |
2025/04/02 | 1,451 | 1,457 | 1,403 | 1,404 | -57 | -3.9% | 8,677,000 |
2025/04/01 | 1,461 | 1,473 | 1,454.5 | 1,461 | +14.5 | +1% | 5,137,800 |
1~
50
件表示中 / 3719件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 141,600円 | +0.9% | +380.2% | 5.51% | 19.50倍 | 1.68倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
第一三共 | 361,100円 | +6.0% | +4.0% | 2.16% | 22.42倍 | 4.14倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
大塚HD | 739,100円 | +2.2% | +10.2% | 1.62% | 14.19倍 | 1.43倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 245,800円 | +20.9% | +10.6% | 2.69% | 11.62倍 | 1.54倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
協和キリン | 248,900円 | -3.5% | -11.3% | 2.41% | 22.86倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム